MVIS US Listed Pharmaceutical 25 Index

The MVIS US Listed Pharmaceutical 25 Index (MVPPH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the pharmaceutical industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from pharmaceutical related products and services, such as research and development, production, or marketing and sales.

Components

The MVIS US Listed Pharmaceutical 25 Index counts currently 25 components. The full list of the components with the respective weights (as of latest close) is available below.

Items 1-25 of total 25
ComponentCountryWeight
ASTRAZENECA PLC-SPONS ADRGB5.47%
MERCK & CO. INC.US5.39%
NOVO-NORDISK A/S-SPONS ADRDK5.27%
ABBVIE INCUS5.14%
SANOFI-ADRFR5.05%
NOVARTIS AG-ADRCH4.94%
JOHNSON & JOHNSONUS4.87%
ELI LILLY & COUS4.84%
BRISTOL-MYERS SQUIBB COUS4.66%
PFIZER INCUS4.63%
MCKESSON CORPUS4.62%
ZOETIS INCUS4.51%
AMERISOURCEBERGEN CORPUS4.50%
GLAXOSMITHKLINE PLC-SPON ADRGB4.49%
MYLAN NVNL4.32%
CATALENT INCUS4.22%
TAKEDA PHARM-ADRJP3.84%
TEVA PHARMACEUTICAL-SP ADRIL3.81%
ELANCO ANIMAL HEALTH INCUS3.62%
ORGANON & COUS3.19%
BAUSCH HEALTH COS INCCA3.02%
JAZZ PHARMACEUTICALS PLCIE2.58%
PERRIGO CO PLCIE1.65%
AMARIN CORPORATION PLC -ADRGB0.77%
PATTERSON COMPANIES INCUS0.60%
Items 1-25 of total 25
Up